OSRX Teams Up with Pro Rodeo Standout Sam Petersen Following Breakout 2025 Season

MISSOULA, Mont.--(BUSINESS WIRE)--Apr 20, 2026--

OSRX, Inc., an FDA-registered outsourcing facility specializing in compounded ophthalmic medications, today announced a partnership with professional rodeo athlete and Montana native Sam Petersen—the 2025 world No. 2 bareback rider and Wrangler National Finals Rodeo average champion. The collaboration advances the company’s Ride with OSRX campaign—an initiative celebrating rising American talent forged through discipline, resilience, and a relentless pursuit of excellence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420902919/en/

Both Petersen and OSRX share roots in Montana—and a competitive mindset built on performance. Known for his grit in and out of the arena, Petersen competes with consistency, control, and the ability to execute under extreme pressure. OSRX applies those same standards to compounded ophthalmic medications, where precision and reliability directly impact patient outcomes. That focus has fueled the company’s rapid growth from a Missoula startup into one of the nation’s largest ophthalmic compounders, now trusted by more than 10,000 prescribers nationwide.

“Montana breeds a certain type of person—and company,” said Eric Garner, Chief Commercial Officer at OSRX. “When you watch Sam ride, you see someone who demands more of himself every single time out. That attitude is exactly how OSRX was built—by doing things the right way, earning trust, and delivering consistently when it matters most. As we continue to grow nationally, partnering with Sam is a natural extension of who we are and where we’re going.”

Petersen echoed the connection between their disciplines. “There’s a lot of overlap in how we think about what we do,” Petersen said. “For me, it’s about putting in the work and performing at the highest level every time I nod my head. You can tell OSRX takes pride in getting the details right and producing great medications.”

Founded in 2019, OSRX formulates compounded ophthalmic medications designed to simplify post-surgical care and support ongoing treatment for conditions such as glaucoma. By streamlining dosing and prioritizing affordable pricing regardless of insurance status, the company is working to expand access to quality, affordable eye care for everyday Americans.

“At the end of the day, performance matters—whether it’s in rodeo or medicine,” Garner added. “We believe patients and providers shouldn’t have to choose between quality care and affordability. That’s what we’re creating, and that’s what Ride with OSRX represents.”

Petersen becomes the latest athlete supported through Ride with OSRX, joining a growing roster of next-generation competitors across high-performance sports, including racing phenom Truly Adams, who is pursuing a pathway to Formula 1. The partnership will include national marketing campaigns, event appearances, and digital content series throughout 2026, featuring behind-the-scenes training, competition coverage, and storytelling from the road.

As Petersen pushes toward a world title in 2026, OSRX will support his journey—reinforcing a shared belief at the core of the campaign: success is earned, not given.

Learn more about OSRX and follow Petersen’s 2026 season through the Ride with OSRX campaign at ridewithosrx.com.

About OSRX

OSRX is an FDA-registered 503B outsourcing facility dedicated to advancing ophthalmic care through high-quality compounded solutions that simplify treatment for prescribers and patients. Operating nationwide, the Montana-based company is trusted by more than 10,000 prescribers and is driven by its vision to deliver high-quality medications at affordable prices. Learn more at www.osrxpharmaceuticals.com.

OSRX glaucoma and other compounded medications carry serious risks, including elevation of intraocular pressure, conjunctivitis, and decreased visual acuity. View potential adverse events and contraindications at: https://osrxpharmaceuticals.com/osrx-api-aecontraindication. For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.

OSRX is proud to sponsor American pro rodeo bareback rider Sam Petersen.

WASHINGTON (AP) — The Justice Department filed a complaint Monday in federal court against the city of Washington, D.C., and its water and sewer authority, seeking financial penalties for their role in a leak that led to millions of gallons of raw sewage spilling into the Potomac River.

The complaint stems from a massive leak in a 72-inch (183-centimeter) pipeline, called the Potomac Interceptor. The pipe collapsed Jan. 19, shooting sewage out of the ground and into the river just north of Washington in Montgomery County, Maryland. The leak spilled 244 million gallons (924 million liters) of raw sewage into the Potomac River and shined a fresh light on the country's aging infrastructure.

The local water authority, DC Water, said it knew the pipe, first installed in the 1960s, was deteriorating, and rehabilitation work on a section about a quarter-mile (400 meters) from the break began in September and was recently completed.

The complaint alleges that DC Water failed to properly operate and maintain its sewer system in a manner that keeps untreated sewage out of the Potomac River and tributaries, and other areas with risk of human contact.

“After decades of use and years of neglect, including at least eight years of DC Water knowing about severe corrosion requiring immediate repair, a section of the Potomac Interceptor known by DC Water to be severely corroded catastrophically failed,” the filing said.

"DC Water's failure to maintain the Potomac Interceptor resulted in raw sewage flowing into the Potomac River and the surrounding environment, posing a direct risk to public health," said Principal Deputy Assistant Attorney General Adam Gustafson in a statement. “As cities grow and infrastructure ages, cities must invest in their wastewater system to prevent such catastrophes.”

The complaint was one of two filed against DC Water Monday. Maryland Attorney General Anthony Brown filed a separate action in Montgomery County Circuit Court seeking civil penalties and damages for costs from the contamination of the river.

“The utility must take full responsibility for the damage caused and take immediate and lasting action to prevent future spills," said Maryland Department of the Environment Secretary Serena McIlwain in a statement.

DC Water said in a statement that it was “fully committed to the long-term rehabilitation” of the Potomac Interceptor. The agency added that its highest priority was to contain the overflow and repair the damaged section of the pipe, which it did in fully stopping “all discharges to the Potomac River within 21 days. The repairs of the affected segment were completed in 55 days. DC Water is working now to accelerate the rehabilitation of more than 2,700 linear feet of pipeline in this area that was previously scheduled for improvement.”

The statement declared that both lawsuits were “under review.”

The leak sparked political recriminations from President Donald Trump — who blamed local Democratic leaders, focusing especially on Maryland's Democratic Gov. Wes Moore. Washington Mayor Muriel Bowser declared an emergency in February and asked Trump for help. He issued an emergency declaration days later that provided a rush of federal assistance.

The pipe was returned to operation last month after emergency repairs were completed.

The leak is largely under control, but it could take months to fully repair the pipe. DC Water, along with the EPA, has been working to repair the leak and monitor the impact on the river.

FILE - Workers prepare to take soil samples where raw sewage flowed near the Potomac River in Cabin John, Md., March 14, 2026. (AP Photo/Cliff Owen, File)